Floatz logo

Allogeneic Human Umbilical Cord Tissue-Derived Mesenchymal Stem Cells

Multiple Sclerosis, Relapsing-Remitting

Genesis LimitedCell therapyPhase 1/2Dormant
CC
45/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
33/ 100
Competitive Position
81/ 100

Competitive context

80 Active assets in the Multiple Sclerosis, Relapsing-Remitting cohort.

Asset / SponsorPhaseRating
Fingolimod
TG Therapeutics, Inc.
Phase 4A
Glatiramer
University Hospital, Montpellier
Phase 4BBB
Natalizumab
Biogen
Phase 4BBB
Interferon ?1 (human fibroblast protein moiety)
Biogen
Phase 4BBB
Cladribine
Uppsala University
Phase 4BBB

View all 50 →

Same molecule, other indications

Allogeneic Human Umbilical Cord Tissue-Derived Mesenchymal Stem Cells is also rated in:

cerebral infarctionDormant
CCC
Indicative ·
50 / 100
View asset →
cirrhosis of liverDormant
CCC
Indicative ·
48 / 100
View asset →
multiple sclerosisDormant
CC
Indicative ·
41 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →